Chris Dall | News Reporter | CIDRAP NewsMay 22, 2020The largest study to date on the use of hydroxychloroquine and chloroquine finds no benefit, but the drugs were associated with a higher risk of hospital death and serious heart rhythm complications.
Malaria drugs tied to risk of death, heart problems in COVID-19 patients
More from COVID-19More posts in COVID-19 »
- Global, US data show high antibiotic use, rise in resistant infections during COVID
- US respiratory virus levels continue to decline as officials track shift in SARS-CoV-2 proportions
- Study reveals promising results for abatacept for severe COVID
- Long-COVID patients more likely to report psychiatric symptoms, cost barriers to therapy